Satoshi Miyakawa’s ‘A Disease Without a Name’ Now Set for Serialization

Thread
Satoshi Miyakawa’s ‘A Disease Without a Name’ Now Set for Serialization

Shogakukan's Big Comic Superior magazine

Satoshi Miyakawa, a manga creator, is set to release a new manga titled Namae no Nai Byōki (A Disease Without a Name) in the 18th issue of Shogakukan’s Big Comic Superior magazine on August 23.

The manga is inspired by the personal story of Miyakawa’s older brother, who has lived as a recluse for three decades.

This touching and poignant story won the grand prize in the magazine’s Superior Document Comic Grand Prize, earning Miyakawa 1 million yen and securing a serialization for the story.

In addition to this, Miyakawa, alongside artist Kawa, recently began a new manga called Ochiai Hiromitsu no Oreryū Tensei (Hiromitsu Ochiai’s Self-Reincarnation) in Kodansha’s Morning magazine.

Satoshi Miyakawa’s ‘A Disease Without a Name’ Now Set for Serialization
A Disease Without a Name (Shogakukan’s Big Comic Superior magazine)

This manga is based on the legendary life of Hiromitsu Ochiai, a former professional baseball player and manager.

Miyakawa’s collaboration with Kawa continues to explore unique and compelling stories, showcasing his versatility as a storyteller.

Miyakawa has also worked on other notable projects, including the Wanope Joker manga, which he co-created with Keisuke Gotō.

This manga, a collaboration between Kodansha’s Morning magazine and DC Comics, wrapped up in 2023.

Another of Miyakawa’s popular works, Uchū Senkan Tiramisu (Space Battleship Tiramisu), co-created with Kei Itō, ran from 2015 to 2020 and even inspired a successful anime series with two seasons, streamed by Crunchyroll and Funimation.

Verified since 2021 Senior Content Writer

Banita Mohanty is a Dehradun-based Senior Content Writer at OtakuKart with a journalism and mass communication degree. She specializes in writing about anime and manga, with particular focus on shoujo and slice-of-life genres, manga industry news, and breaking announcements from publishers like Shueisha and Square Enix.

THREAD

Share your take. All comments are held for review before appearing.

Be the first to share your thoughts.